UT Southwestern Study Identifies How Certain Drugs Alter the Metabolism of Pancreatic Cancer Cells, Revealing a New Therapeutic Target
Thursday, January 21, 2016 - 13:58
in Health & Medicine
UT Southwestern Medical Center researchers have found that cancer drugs known as CDK4/6-inhibitors alter the metabolism of pancreatic cancer cells, revealing a biologic vulnerability that could be exploited for therapeutic gain.